1. A. Sertkaya, A. Birkenbach, A. Berlind, J. Eyraud, Eastern Research Group, Inc., Examination of clinical trial costs and barriers for drug development, https://aspe.hhs.gov/reports/examination-clinical-trial-costs-barriers-drug-development-0. Accessed 19 June 2022
2. T.U. Singh, S. Parida, M.C. Lingaraju, M. Kesavan, D. Kumar, R.K. Singh, Drug repurposing approach to fight COVID-19. Pharmacol. Rep. 72(6), 1479–1508 (2020)
3. M. Allegretti, M.C. Cesta, M. Zippoli, A. Beccari, C. Talarico, M. Mantelli et al., Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection. Cell Death Differ. 29(1), 156–166 (2022)
4. V. Parvathaneni, N.S. Kulkarni, A. Muth, V. Gupta, Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discov. Today. 24(10), 2076–2085 (2019)
5. D. Gadioli, E. Vitali, F. Ficarelli, C. Latini, C. Manelfi, C. Talarico, et al., EXSCALATE: An extreme-scale in-silico virtual screening platform to evaluate 1 trillion compounds in 60 hours on 81 PFLOPS supercomputers. Preprint posted online 22 Oct 2021